Vibativ develops and commercializes injectable lipoglycopeptide antibiotics for the treatment of bacterial pneumonia... Read more
Vibativ develops and commercializes injectable lipoglycopeptide antibiotics for the treatment of bacterial pneumonia... Read more
CEO
Add
Est. Annual Revenue
$ < 1M
Est. Employees
<10
News
Feb 19, 2025
Pharamceutical Technology
VIBATIV: Cumberland's Vibativ injection gains China's NMPA approval
Oct 11, 2023
centralcharts
Press Release: VIBATIV : NEW VIBATV PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE
May 27, 2020
The Pharma Letter
VIBATIV: Cumberland's Vibativ scores in real-world setting
May 11, 2020
PR Newswire
Press Release: VIBATIV : Vibativ Sustained Potency Confirmed In Two Surveillance Studies
Nov 08, 2018
Global FDI
VIBATIV: Cumberland Pharmaceuticals To Acquire VIBATIV
Nov 06, 2018
The Tennessean
VIBATIV: Nashville pharma company buys powerful antibiotic for $25M
Apr 23, 2018
PR Newswire
Press Release: VIBATIV : Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV® (telavancin) at 2018 ECCMID Conference
VIBATIV Competitors
1
2
3
4
5
6
7
8
9
10